More specifically, in patients with MCI and Alzheimer’s dementia, Benjanin and colleagues (2017) reported an association between regional tau PET binding and cognitive impairment, which was partly mediated by grey matter volumes. This evidence concerns the gene MAPT and Alzheimer disease.